YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
GAITHERSBURG, Md., Jan. 22, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. along with its subsidiaries , a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and...